PE62796A1 - Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiol - Google Patents
Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiolInfo
- Publication number
- PE62796A1 PE62796A1 PE1995287516A PE28751695A PE62796A1 PE 62796 A1 PE62796 A1 PE 62796A1 PE 1995287516 A PE1995287516 A PE 1995287516A PE 28751695 A PE28751695 A PE 28751695A PE 62796 A1 PE62796 A1 PE 62796A1
- Authority
- PE
- Peru
- Prior art keywords
- estradiol
- precursor
- drug release
- release device
- device containing
- Prior art date
Links
- 239000002243 precursor Substances 0.000 title abstract 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229960005309 estradiol Drugs 0.000 abstract 3
- -1 HYDROXYL GROUP Chemical group 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- 239000012153 distilled water Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 229920001296 polysiloxane Polymers 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE AL DISPOSITIVO QUE COMPRENDE UN PRECURSOR DE 17�-ESTRADIOL TAL COMO 17�-ESTRADIOL-3-ACETATO, EN UNA MATRIZ DE POLIMEROS; ESTANDO ADAPTADO PARA LIBERAR EL PRECURSOR EN UN MODELO DE ORDEN CERO, DURANTE POR LO MENOS TRES SEMANAS; SIENDO EL PRECURSOR UNA MITAD DE 17�-ESTRADIOL, EN DONDE EL O CADA GRUPO HIDROXILO DE LA MITAD 17�-ESTRADIOL ES BLOQUEADA POR UN GRUPO BLOQUEANTE TAL COMO ACILO DE CADENA CORTA ALIFATICA O PROPIONILO, EL CUAL ES FACILMENTE ELIMINADO; TENIENDO EL PRECURSOR LIPOFILICIDAD O SOLUBILIDAD EN SILICONA LIQUIDA DE NO MENOS DE 0,1 mg/100ml; UN VALOR K ESTANDAR DE NO MENOS DE 0,1 �g/d/mm; HIDROFILICIDAD, SEGUN SE DETERMINA POR LA SOLUBILIDAD EN AGUA DESTILADA DE NO MENOS DE 1 �g/100ml
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IES940976 | 1994-12-19 | ||
| IES950247 | 1995-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE62796A1 true PE62796A1 (es) | 1996-12-28 |
Family
ID=26319777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1995287516A PE62796A1 (es) | 1994-12-19 | 1995-12-19 | Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiol |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5855906A (es) |
| EP (1) | EP0799025B1 (es) |
| JP (1) | JPH10510825A (es) |
| CN (1) | CN1138526C (es) |
| AR (1) | AR002010A1 (es) |
| AT (1) | ATE178204T1 (es) |
| AU (1) | AU692659B2 (es) |
| CA (1) | CA2207622C (es) |
| DE (1) | DE69508791T2 (es) |
| DK (1) | DK0799025T3 (es) |
| ES (1) | ES2133841T3 (es) |
| FI (1) | FI119414B (es) |
| GR (1) | GR3030614T3 (es) |
| IL (1) | IL116433A (es) |
| NO (1) | NO316707B1 (es) |
| NZ (1) | NZ298490A (es) |
| PE (1) | PE62796A1 (es) |
| TR (1) | TR199501599A2 (es) |
| WO (1) | WO1996019196A1 (es) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
| US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
| US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
| US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
| US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
| NZ501236A (en) * | 1997-05-07 | 2002-02-01 | Galen Chemicals Ltd | Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors in a polymer matrix and surrounded by a sheath |
| US6039968A (en) * | 1997-06-24 | 2000-03-21 | Hoechst Marion Roussel | Intravaginal drug delivery device |
| US20040176336A1 (en) * | 2000-03-21 | 2004-09-09 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US20050113351A1 (en) * | 2000-03-21 | 2005-05-26 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
| US6811549B2 (en) * | 2001-02-16 | 2004-11-02 | William H. Fleming | Administration of therapeutic or diagnostic agents using interlabial pad |
| US6962908B2 (en) * | 2001-12-21 | 2005-11-08 | Warner Chilcott Company Inc. | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| EP1494646B2 (en) * | 2002-03-27 | 2017-10-04 | Warner Chilcott (Ireland) Limited | Intravaginal matrix drug delivery devices |
| GB0222522D0 (en) * | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
| ATE461681T1 (de) * | 2003-04-29 | 2010-04-15 | Gen Hospital Corp | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln |
| GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
| WO2006084082A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
| EP1853221A2 (en) * | 2005-02-03 | 2007-11-14 | Duramed Pharmaceuticals, Inc. | Devices for delivering agents to a vaginal tract |
| US20100003297A1 (en) | 2005-08-11 | 2010-01-07 | Massachusetts Institute Of Technology | Implantable Drug Delivery Device and Methods of Treating Male Genitourinary and Surrounding Tissues |
| DK1933810T3 (da) * | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
| US20070077269A1 (en) * | 2005-10-04 | 2007-04-05 | Woodward John R | Method of birth control and hormone regulation |
| BRPI0617325B8 (pt) * | 2005-10-13 | 2021-06-22 | Synthes Gmbh | luva biologicamente compatível |
| GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
| GB0613638D0 (en) * | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
| US20080160065A1 (en) * | 2006-07-12 | 2008-07-03 | Janet Anne Halliday | Drug delivery polymer with hydrochloride salt of clindamycin |
| GB0620685D0 (en) * | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
| SG195525A1 (en) | 2007-06-26 | 2013-12-30 | Warner Chilcott Co Llc | Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| DK2231254T3 (da) * | 2007-12-11 | 2014-07-21 | Massachusetts Inst Technology | Implanterbar lægemiddelafgivelsesindretning |
| JP5695035B2 (ja) | 2009-06-03 | 2015-04-01 | フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． | 前眼部薬物供給 |
| US8343516B2 (en) | 2009-06-26 | 2013-01-01 | Taris Biomedical, Inc. | Solid drug tablets for implantable drug delivery devices |
| US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
| US9114111B2 (en) | 2011-01-10 | 2015-08-25 | Allergan, Inc. | Methods for sustained treatment of bladder pain and irritative voiding |
| WO2012106714A1 (en) | 2011-02-04 | 2012-08-09 | Taris Biomedical, Inc. | Implantable device for controlled release of low solubility drug |
| ES2912370T3 (es) | 2011-09-14 | 2022-05-25 | Forsight Vision5 Inc | Aparato para inserción ocular |
| TWI590843B (zh) | 2011-12-28 | 2017-07-11 | 信迪思有限公司 | 膜及其製造方法 |
| CN104884006B (zh) | 2012-10-26 | 2017-12-15 | 弗赛特影像5股份有限公司 | 用于持续释放药物到眼睛的眼科系统 |
| SG11201507294WA (en) | 2013-03-15 | 2015-10-29 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| KR102249720B1 (ko) | 2013-06-21 | 2021-05-11 | 디퍼이 신테스 프로덕츠, 인코포레이티드 | 필름 및 제조 방법 |
| WO2015026813A1 (en) | 2013-08-19 | 2015-02-26 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
| CN104546668B (zh) * | 2013-10-23 | 2019-03-05 | 国家卫生计生委科学技术研究所 | 液体硅橡胶为载体的药物缓控释系统的制备及应用 |
| US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
| CN112494195A (zh) * | 2014-04-01 | 2021-03-16 | 保利医学公司 | 避孕装置及相关装置 |
| WO2016168141A1 (en) | 2015-04-13 | 2016-10-20 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
| WO2016172704A1 (en) | 2015-04-23 | 2016-10-27 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| CN114573654B (zh) * | 2020-12-01 | 2025-09-12 | 北京奇明达企业管理有限公司 | 17-O-乙酰-17-β雌二醇的自组装的三聚体、其制备、活性和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3545439A (en) * | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
| US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
| US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
| SE8602666D0 (sv) * | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
-
1995
- 1995-12-18 IL IL11643395A patent/IL116433A/en not_active IP Right Cessation
- 1995-12-19 WO PCT/IE1995/000063 patent/WO1996019196A1/en not_active Ceased
- 1995-12-19 AU AU43991/96A patent/AU692659B2/en not_active Ceased
- 1995-12-19 ES ES95942772T patent/ES2133841T3/es not_active Expired - Lifetime
- 1995-12-19 TR TR95/01599A patent/TR199501599A2/xx unknown
- 1995-12-19 US US08/849,329 patent/US5855906A/en not_active Expired - Lifetime
- 1995-12-19 DK DK95942772T patent/DK0799025T3/da active
- 1995-12-19 PE PE1995287516A patent/PE62796A1/es not_active Application Discontinuation
- 1995-12-19 CA CA002207622A patent/CA2207622C/en not_active Expired - Lifetime
- 1995-12-19 AT AT95942772T patent/ATE178204T1/de not_active IP Right Cessation
- 1995-12-19 DE DE69508791T patent/DE69508791T2/de not_active Expired - Lifetime
- 1995-12-19 EP EP95942772A patent/EP0799025B1/en not_active Expired - Lifetime
- 1995-12-19 NZ NZ298490A patent/NZ298490A/xx unknown
- 1995-12-19 CN CNB951968947A patent/CN1138526C/zh not_active Expired - Lifetime
- 1995-12-19 AR ARP950100619A patent/AR002010A1/es unknown
- 1995-12-19 JP JP8519650A patent/JPH10510825A/ja not_active Ceased
-
1997
- 1997-06-17 NO NO19972798A patent/NO316707B1/no unknown
- 1997-06-17 FI FI972579A patent/FI119414B/fi not_active IP Right Cessation
-
1999
- 1999-06-29 GR GR990401699T patent/GR3030614T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO316707B1 (no) | 2004-04-13 |
| IL116433A0 (en) | 1996-03-31 |
| NO972798L (no) | 1997-08-19 |
| DK0799025T3 (da) | 1999-10-18 |
| ATE178204T1 (de) | 1999-04-15 |
| CN1170353A (zh) | 1998-01-14 |
| EP0799025B1 (en) | 1999-03-31 |
| AU4399196A (en) | 1996-07-10 |
| AR002010A1 (es) | 1998-01-07 |
| IL116433A (en) | 2002-02-10 |
| NO972798D0 (no) | 1997-06-17 |
| US5855906A (en) | 1999-01-05 |
| FI972579A0 (fi) | 1997-06-17 |
| EP0799025A1 (en) | 1997-10-08 |
| TR199501599A2 (tr) | 1996-07-21 |
| JPH10510825A (ja) | 1998-10-20 |
| AU692659B2 (en) | 1998-06-11 |
| WO1996019196A1 (en) | 1996-06-27 |
| NZ298490A (en) | 1999-11-29 |
| GR3030614T3 (en) | 1999-10-29 |
| CA2207622A1 (en) | 1996-06-27 |
| DE69508791T2 (de) | 1999-12-02 |
| CN1138526C (zh) | 2004-02-18 |
| CA2207622C (en) | 2006-10-17 |
| FI119414B (fi) | 2008-11-14 |
| DE69508791D1 (de) | 1999-05-06 |
| ES2133841T3 (es) | 1999-09-16 |
| FI972579L (fi) | 1997-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE62796A1 (es) | Dispositivo de liberacion de droga intravaginal conteniendo un precursor de 17b-estradiol | |
| AR065073A2 (es) | Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo | |
| KR890004709A (ko) | 항원충제로서의 아지트로마이신 및 이의 유도체 | |
| CR6656A (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| BR0209198A (pt) | Métodos de sìntese de compostos contendo fenol | |
| PE20020307A1 (es) | Forma de dosificacion de farmaco activada por hidrogel | |
| BR0005915A (pt) | Comprimido matriz que possibilita a liberação prolongada de trimetazidina após a administração pela via oral | |
| ES2188787T3 (es) | Compuesto medicamentoso de micela copolimera y metodo para su preparacion. | |
| MX9304711A (es) | Sistema de reaccion para la preparacion de elastomeros microcelulares. | |
| BR0014181A (pt) | Recipiente de policarbonato ramificado | |
| ES8403024A1 (es) | Un procedimiento para la fabricacion de un preparado farmaceutico para uso externo, a base de un compuesto no esteroi- dico. | |
| KR890006644A (ko) | 결정성 β-락탐 수화물 | |
| BR0116438A (pt) | Composição catalìtica e métodos para a preparação da mesma e o uso da mesma em um processo de polimerização | |
| ES2157221T3 (es) | Composiciones metaloporfirinicas. | |
| BR0010521A (pt) | Composições farmacêuticas destinadas a administração por via oral de floroglucinol e sua preparação | |
| ES2021904A6 (es) | Procedimiento para preparar una composicion farmaceutica a base de un acido piperacinacarboxilico. | |
| ES2140887T3 (es) | Procedimiento para cristalizar en agua (s)-n-n'-bis(2-hidroxi-1-(hidroximetil)etil)-5-((2-hidroxi-1-oxopropil)amino)-2,4,6-triyodo-1,3-bencenodicarboxamida. | |
| AR002981A1 (es) | Un envase que aloja una composicion farmaceutica que comprende una solucion acuosa de clorhidrato de procaterol, y una composicion farmaceutica quecomprende una solucion acuosa de clorhidrato de procaterol | |
| ES2092559T3 (es) | Formulacion farmaceutica que contiene penciclovir. | |
| LEE et al. | Anxiety, depression and impulsiveness according to military service duration in army-enlisted males | |
| MX172773B (es) | Proceso para inhibir la adhesion bacterial y controlar el pudrimiento biologico en los sistemas acuosos | |
| ME | Formulation and in-vitro evaluation of levonorgestrel as well as copper releasing iud [procopper iud] | |
| CO4700301A1 (es) | Dispositivo para suministro intravaginal de drogas para ad- ministracion de precursores de 17b-estradiol | |
| MX9703839A (es) | Soluciones intravenosas de lubeluzol. | |
| Ahn et al. | The effect of an anticholinergic agent (oxybutynin) on spontaneous resolution of primary vesicoureteral reflux |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |